TLSA - Tiziana Life Sciences Ltd logo

TLSA

Tiziana Life Sciences Ltd

Net —top 1%Rev —top 1%20Y
Hold

Tiziana Life Sciences Ltd develops therapies for neurodegenerative and lung diseases. Its key products include Foralumab, a monoclonal antibody for various immune disorders, and TZLS-501, targeting the IL-6 receptor for inflammatory and oncology treatments.

⚕️ Healthcare NASDAQ Listed 2000 £ GBP
$1,000 invested 5 years ago $535today

Score Overview

1 Year
Score
Net Growth
Net Trend
Net Income Consistency
Rev Growth
Rev Trend
Revenue Consistency
5 Years
Score
Net Growth
Net Trend50%
Net Income Consistency
Rev Growth
Rev TrendNever
Revenue Consistency
10 Years
Score
Net Growth
Net Trend44%
Net Income Consistency
Rev Growth
Rev TrendNever
Revenue Consistency
20 Years
Score
Net Growth
Net Trend53%
Net Income Consistency
Rev Growth
Rev Trend12%
Revenue Consistency
All Time
Score
Net Growth
Net Trend52%
Net Income Consistency
Rev Growth
Rev Trend21%
Revenue Consistency

See the full market ranking →

Tiziana Life Sciences Ltd fundamental performance

Across Tiziana Life Sciences Ltd's full reported history, from 2000 to 2025, net income went from -£ 2M to -£ 18M. Revenue increased in 21% of the years measured; net income in 52%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 0.99
1 Year2025-08-12
$ 2.23-55.61%
5 Years2021-08-12
$ 1.85-46.49%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026£ 4M
2025£ 0.00-£ 18M£ 4M
2024£ 0.00-£ 11M£ 3M
2023£ 0.00-£ 22M£ 1M
2022£ 0.00-£ 18M£ 18M
2021£ 0.00-£ 31M£ 42M
2020£ 0.00-£ 35M£ 65M
2019£ 0.00-£ 9M£ 153K
2018£ 0.00-£ 7M£ 5M
2017£ 0.00-£ 6M£ 48K
2016£ 0.00-£ 7M£ 4M
2015£ 0.00-£ 12M£ 8M
2014£ 0.00-£ 3M£ 2M
2013£ 3K-£ 280K£ 76K
2012-£ 848K£ 20K
2011-£ 127.31K-£ 1M£ 455K
2010£ 187.34K-£ 4M£ 70.25K
2009£ 56K-£ 730K£ 30K
2008£ 92K-£ 1M£ 25K
2007£ 64K-£ 2M£ 588K
2006£ 405K-£ 2M£ 508K
2005£ 116K-£ 2M£ 941K
2004£ 99K-£ 1M£ 771K
2003-£ 1M£ 996K
2002-£ 2M£ 543K
2001-£ 2M£ 1M
IPO2000-£ 2M£ 2M

Explore beyond TLSA

You're looking at Tiziana Life Sciences Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies